Selective internal radiotherapy (SIRT) fails to extend survival in the SORAMIC study palliative cohort

The final results of the palliative cohort of the SORAMIC study in patients with un-resectable, locally advanced primary liver cancer have confirmed no clinical advantage to adding selective internal radiation therapy (SIRT) to standard sorafenib treatment compared with using sorafenib alone.